Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Macau
EQS Group
Shanghai, China – May 8, 2024 — Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company..